Healthcare -
Biotechnology - NASDAQ - US
$ 47.58
-3.14 %
$ 3.57 B
Market Cap
-12.69
P/E
AKRO - RESEARCH & DEVELOPMENT
Research & Development AKRO - Akero Therapeutics, Inc.
142 M
LAST VALUE
31.69%
2 YEAR CAGR
64.19%
5 YEAR CAGR
0.00%
10 YEAR CAGR